7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-09-30 2016-06-30 2016-03-31 
      
    		                                      
      operating activities:
    		                                      
      net income
    		124,841,000 94,320,000 1,270,000 -151,881,000 -121,350,000 -120,405,000 -251,150,000 -367,553,000 215,413,000 -381,137,000 -348,431,000 -445,335,000 -552,757,000 -571,449,000 -434,274,000 -585,653,000 -413,855,000 -480,341,000 66,495,000 -472,649,000 -426,617,000 -336,318,000 -364,939,000 -387,895,000 -308,660,000 -85,954,000 -168,069,000 -266,710,000 -144,492,000 -157,715,000 -105,116,000        
      adjustments to reconcile net income to net cash from operating activities:
    		                                      
      depreciation and amortization expense
    		37,284,000 35,614,000 32,804,000 50,246,000 71,292,000 24,931,000 25,293,000 23,819,000 21,510,000 22,335,000 20,011,000 18,016,000 16,201,000 15,461,000 16,600,000 13,121,000 12,177,000 11,527,000 9,632,000 7,828,000 8,344,000 7,867,000 7,750,000 7,484,000 4,022,000 3,695,000 3,416,000 3,363,000 2,445,000 2,336,000 2,244,000        
      share-based compensation expenses
    		140,809,000 150,809,000 95,478,000  114,697,000 130,637,000 88,667,000  96,004,000 103,371,000 75,322,000  78,176,000 81,305,000 65,555,000  67,077,000 64,791,000 45,833,000  50,297,000 45,468,000 38,255,000  36,818,000 32,602,000 26,392,000 25,958,000 25,132,000 18,641,000 17,396,000     2,779,000 1,285,000 2,614,000 
      acquired in-process research and development
    		191,000       31,800,000    48,665,000    30,000,000 0 45,000,000 8,500,000 20,000,000 46,500,000 0 43,000,000 20,000,000 0 20,000,000 29,000,000 60,000,000 0 0 10,000,000        
      amortization of research and development cost share liability
    		-29,275,000 -25,757,000 -19,812,000 -21,612,000 -16,575,000 -21,903,000 -13,136,000 -16,725,000 -15,900,000 -5,271,000 -17,398,000 -26,013,000 -24,806,000 -23,764,000 -21,819,000 -29,640,000 -28,944,000 -26,972,000 -26,930,000 -28,690,000 -30,056,000 -27,606,000 -27,634,000                
      impairment of equity investments
    		                                      
      other items
    		-5,533,000 2,759,000 12,369,000 -353,000 6,103,000 4,565,000 848,000 -6,820,000 55,000 192,000 575,000 1,285,000 1,402,000 2,816,000 3,544,000 5,791,000 6,507,000 5,949,000 5,263,000 5,490,000 2,007,000 242,000 -1,105,000                
      changes in operating assets and liabilities:
    		                                      
      accounts receivable
    		-93,925,000 -41,503,000 -31,866,000 -125,699,000 -29,848,000 -93,871,000 -80,025,000 -44,795,000 -11,588,000 4,564,000 -136,487,000 19,395,000 -22,713,000 14,876,000 292,554,000 -353,845,000 -55,836,000 10,318,000 -23,656,000 -134,000 1,403,000 5,858,000 3,236,000 -14,966,000 2,196,000 868,000 -17,920,000 -3,684,000 -4,201,000 -9,686,000 5,943,000        
      inventories
    		-28,836,000 2,187,000 3,987,000 -79,384,000 23,837,000 1,315,000 -37,264,000 -88,577,000 1,227,000 -40,571,000 -13,027,000 18,943,000 -43,999,000 -28,631,000 -3,002,000 -91,647,000 -33,392,000 -44,613,000 16,319,000 -51,934,000 -2,291,000 -4,459,000 -222,000 8,959,000 11,536,000 -35,908,000 3,102,000 3,457,000 -13,377,000 1,176,000 3,432,000        
      other assets
    		100,563,000 -75,053,000 29,737,000 35,621,000 41,738,000 -27,832,000 -4,401,000 29,718,000 13,029,000 19,781,000 -50,408,000 -33,607,000 -1,990,000 49,268,000 -16,953,000 -14,190,000 -15,734,000                      
      accounts payable
    		28,471,000 -4,284,000 -31,568,000 107,961,000 11,344,000 -44,108,000 46,300,000 -9,882,000 64,044,000 -10,089,000 -22,589,000 -8,555,000 34,565,000 4,662,000 -35,024,000 32,384,000 30,182,000 30,620,000 -73,178,000 73,856,000 -12,872,000 56,301,000 -21,450,000 10,375,000 -29,582,000 41,795,000 -20,364,000 17,893,000 -4,731,000 28,795,000 -18,487,000  8,178,000 4,768,000 8,474,000    
      accrued expenses and other payables
    		90,261,000 127,985,000 -52,360,000 56,716,000 82,894,000 51,053,000 -79,309,000 130,022,000 58,171,000 30,599,000 -38,681,000 43,999,000 -17,897,000 93,567,000 -74,042,000 139,225,000 -869,000 35,698,000 -34,010,000 66,821,000 71,401,000 28,696,000 15,775,000 30,536,000 29,959,000 12,325,000 -8,790,000 24,259,000 845,000 19,324,000 6,115,000  22,241,000 -2,036,000 2,166,000 7,489,000 2,649,000 3,222,000 
      other liabilities
    		3,486,000 -3,979,000 4,043,000 -14,233,000 241,000 -186,000 -660,000 532,000 -33,000 -109,000 197,000 -1,376,000 2,281,000 -400,000 -1,714,000 -6,058,000 249,000                      
      net cash from operating activities
    		402,553,000 263,598,000 44,082,000 75,160,000 188,369,000 -95,588,000 -308,572,000 -221,638,000 -78,150,000 -293,888,000 -563,777,000 -318,191,000 -561,906,000 -379,959,000 -236,563,000 -507,839,000 -495,713,000 -420,266,000 125,095,000 -332,334,000 -346,241,000 -262,942,000 -341,944,000 -267,181,000 -265,012,000 -46,101,000 -171,975,000 -193,894,000 -132,185,000 -117,137,000 -104,501,000 93,749,000 6,600,000      
      capex
    		-48,084,000 -43,826,000 -56,407,000 0 -133,655,000 -109,950,000 -156,578,000 0 -157,882,000 -121,470,000 -125,585,000 0 -108,655,000 -50,290,000 -45,131,000 0 -67,043,000 -38,531,000 -42,389,000 0 -28,681,000 -32,605,000 -21,533,000 0 -30,873,000 -21,447,000 -21,828,000 -23,254,000 -26,720,000 -10,613,000 -9,696,000 0 -18,560,000      
      free cash flows
    		354,469,000 219,772,000 -12,325,000 75,160,000 54,714,000 -205,538,000 -465,150,000 -221,638,000 -236,032,000 -415,358,000 -689,362,000 -318,191,000 -670,561,000 -430,249,000 -281,694,000 -507,839,000 -562,756,000 -458,797,000 82,706,000 -332,334,000 -374,922,000 -295,547,000 -363,477,000 -267,181,000 -295,885,000 -67,548,000 -193,803,000 -217,148,000 -158,905,000 -127,750,000 -114,197,000 93,749,000 -11,960,000      
      investing activities:
    		                                      
      purchases of property, plant and equipment
    		-48,084,000 -43,826,000 -56,407,000  -133,655,000 -109,950,000 -156,578,000  -157,882,000 -121,470,000 -125,585,000  -108,655,000 -50,290,000 -45,131,000  -67,043,000 -38,531,000 -42,389,000  -28,681,000 -32,605,000 -21,533,000  -30,873,000 -21,447,000 -21,828,000            
      purchase of intangible asset
    		0    0 0 -4,674,000                                
      proceeds from sale or maturity of investments
    		0 0 1,800,000  0 0 2,655,000  19,000 190,538,000 376,962,000  301,370,000 720,000,000 331,028,000  760,876,000 890,515,000 1,107,000,000 778,467,000 975,366,000 740,499,000 256,743,000  384,537,000 456,893,000 710,598,000            
      purchase of in-process research and development
    		-691,000 0 -60,000,000 0 0 0 -31,800,000 0    -48,665,000 -20,000,000 0 -75,000,000 0 0 0 -8,500,000 -20,000,000 -46,500,000 0 -43,000,000 -20,000,000 0 -20,000,000 -29,000,000 -60,000,000 0 0 -10,000,000        
      other investing activities
    		-499,000 -2,779,000 -7,334,000 17,881,000 -227,000 -1,082,000 -19,434,000    -9,250,000      0                      
      net cash from investing activities
    		-49,274,000 -66,605,000 -121,941,000 -93,605,000 -133,882,000 -111,032,000 -209,831,000 -62,584,000 -186,275,000 67,800,000 241,063,000 38,536,000 169,484,000 658,710,000 210,393,000 109,110,000 -11,995,000 251,596,000 291,948,000 -86,925,000 -1,536,577,000 -429,895,000 -1,114,969,000 -23,892,000 213,630,000 192,009,000 172,416,000 213,243,000   -394,352,000 -68,242,000   43,543,000   40,343,000 
      financing activities:
    		                                      
      proceeds from sale of future royalties
    		                                      
      proceeds from long-term loan
    		   0 0 0 9,053,000 0 6,731,000   0    0 6,019,000 155,000 10,664,000       7,009,000 36,695,000 0 0       7,640,000   
      repayment of long-term loan
    		-4,263,000 -12,584,000 -4,215,000 -10,450,000 -3,561,000 -10,441,000 -3,579,000 -5,228,000   -1,457,000                 0           
      proceeds from short-term loans
    		0 141,521,000 80,000,000 543,858,000 0 182,384,000 142,028,000 498,916,000 768,000   150,000,000 96,188,000 17,586,000 50,000,000 262,993,000 30,867,000 41,588,000 71,001,000                    
      repayment of short-term loans
    		0 -102,861,000 -172,921,000 -546,726,000 0   -150,000,000 -93,002,000 -16,574,000 -50,000,000 -271,653,000 -30,023,000 -42,258,000 -73,147,000 -281,525,000                       
      payments of withholding taxes from share-based awards
    		0                                      
      proceeds from option exercises and employee share purchase plan
    		80,535,000 33,144,000 63,359,000 8,795,000 16,223,000 5,564,000 14,791,000 3,360,000 17,183,000 3,580,000 31,589,000 11,287,000 16,705,000 7,092,000 11,880,000 10,570,000 46,591,000 9,847,000 25,754,000 17,271,000 47,632,000 16,569,000 11,629,000 26,617,000 9,745,000 4,373,000 6,269,000            
      other financing activities
    		   0 0                                  
      net cash from financing activities
    		961,272,000 35,025,000 -33,777,000 -4,523,000 12,662,000 23,017,000 162,293,000 347,048,000 -76,782,000 166,080,000 -19,868,000 -110,366,000 120,242,000 -17,580,000 -11,267,000 3,384,654,000 109,207,000 35,631,000 107,419,000 325,658,000 1,994,007,000 80,993,000 2,802,168,000 2,198,000 25,136,000 15,382,000 42,964,000 8,803,000 871,250,000 46,583,000 763,901,000 3,048,000 339,708,000 145,067,000 2,533,000 7,640,000 4,521,000 170,049,000 
      effect of foreign exchange rate changes
    		9,905,000 23,477,000 3,480,000 -51,713,000 28,348,000 -5,902,000 -22,438,000 42,266,000 525,000 -62,184,000 11,311,000 64,546,000 -62,717,000 -80,212,000 9,000,000 7,266,000 1,512,000 9,318,000 -4,061,000 13,891,000 8,627,000 1,925,000 -6,212,000 8,827,000 -15,607,000 -6,997,000 4,265,000 1,765,000 -7,644,000 -1,661,000 3,444,000  2,522,000     86,000 
      net increase in cash, cash equivalents, and restricted cash
    		1,324,456,000             180,959,000 -28,437,000 2,993,191,000 -396,989,000 -123,721,000 520,401,000 -79,710,000 119,816,000 -609,919,000 1,339,043,000 -280,048,000 -41,853,000 154,293,000 47,670,000 29,917,000 240,785,000 -38,083,000 268,492,000        
      cash, cash equivalents, and restricted cash at beginning of period
    		0 0 2,638,747,000  0 0 3,185,984,000  0 0 3,875,037,000  0 0 4,382,887,000  0 0 1,390,005,000  0 0 620,775,000  0 0 740,713,000  0          
      cash, cash equivalents, and restricted cash at end of period
    		1,324,456,000 255,495,000 2,530,591,000  95,497,000 -189,505,000 2,807,436,000  -340,682,000 -122,192,000 3,543,766,000  -334,897,000 180,959,000 4,354,450,000  -396,989,000 -123,721,000 1,910,406,000  119,816,000 -609,919,000 1,959,818,000  -41,853,000 154,293,000 788,383,000  240,785,000          
      supplemental cash flow information:
    		                                      
      cash and cash equivalents
    		1,280,812,000 239,645,000 2,516,411,000 -74,523,000 109,278,000 -200,715,000 2,793,370,000 104,464,000 -343,032,000 -128,276,000 3,538,644,000 -327,568,000 -334,005,000 183,975,000 4,347,162,000 2,992,368,000 -393,138,000 -125,371,000 1,901,819,000 -82,520,000 119,456,000 -612,087,000 1,957,101,000  -62,797,000 154,456,000 764,492,000  205,065,000 -52,214,000 490,634,000        
      short-term restricted cash
    		37,185,000 4,469,000 11,333,000 28,000 -13,871,000 11,710,000 11,445,000 -75,000 1,855,000 9,534,000 159,000 5,000 -142,000 3,000 330,000 -2,000 20,000 5,000 305,000 12,000 12,000 1,000 282,000                
      long-term restricted cash
    		6,459,000 11,381,000 2,847,000 -186,000 90,000 -500,000 2,621,000 703,000 495,000 -3,450,000 4,963,000 2,088,000 -750,000 -3,019,000 6,958,000 825,000 -3,871,000 1,645,000 8,282,000 2,798,000 348,000 2,167,000 2,435,000                
      income taxes paid
    		2,929,000 67,712,000 9,321,000 14,652,000 9,142,000 43,146,000 2,490,000 13,487,000 9,987,000 24,913,000 7,616,000 4,494,000 570,000 23,700,000 736,000 481,000 687,000 14,049,000 478,000 0 1,346,000 8,719,000 531,000  1,077,000 7,514,000 360,000  309,000 11,513,000 329,000  683,000 670,000 76,000 0 0 25,000 
      interest expense paid
    		12,130,000 11,812,000 12,206,000  14,014,000 12,708,000 11,440,000                   1,202,000 888,000  879,000 336,000 331,000  322,000 313,000 305,000 268,000 134,000 108,000 
      supplemental non-cash information:
    		                                      
      capital expenditures included in accounts payable and accrued expenses
    		-5,866,000 -2,087,000 60,010,000  -40,247,000 15,091,000 100,473,000  12,207,000 31,391,000 64,013,000                            
      rou assets obtained in exchange for new operating lease liabilities
    		986,000 2,482,000 15,659,000                                    
      increase in equity investment from deconsolidation of a subsidiary
    		    0 0 40,798,000                                
      gain on deconsolidation of a subsidiary
    		     0 -3,735,000             0                   
      net decrease in cash, cash equivalents, and restricted cash
    		  -108,156,000 -74,681,000 95,497,000 -189,505,000 -378,548,000  -340,682,000 -122,192,000 -331,271,000                            
      cash flows from operating activities:
    		                                      
      share-based compensation expense
    		                                13,327,000 7,082,000 5,992,000    
      unrealized losses on long-term investments
    		                                      
      deferred income tax expense
    		                                      
      gain on bms termination settlement
    		       0                               
      deferred revenue
    		   156,000 261,000   0 -183,010,000 -39,511,000 -33,066,000 -38,996,000 -36,083,000 -37,061,000 -39,676,000 282,805,000 -13,979,000 -11,368,000 150,245,000     0 0 -25,744,000 -2,238,000 -3,383,000 -2,234,000 -1,703,000 -1,739,000        
      cash flows from investing activities:
    		                                      
      purchases of property and equipment
    		                           -23,254,000 -26,720,000 -10,613,000 -9,696,000  -18,560,000      
      proceeds from sale or maturity of short-term investments
    		                                      
      purchase of intangible assets
    		                           -332,000           
      purchase of long-term investments
    		                                      
      cash flows from financing activities:
    		                                      
      cash, cash equivalents, and restricted cash, beginning of year
    		                                      
      cash, cash equivalents, and restricted cash, end of year
    		                                      
      supplemental cash flow disclosures:
    		                                      
      interest paid
    		         4,998,000 5,017,000 5,304,000 6,966,000 6,282,000 6,617,000 6,569,000 9,131,000 7,340,000 6,927,000 2,553,000 38,223,000 2,218,000 1,136,000                
      supplemental non-cash activities:
    		                                      
      accruals for capital expenditures
    		                                      
      purchase of in-process research and development included in accounts payable
    		                                      
      acquired intangible asset included in accounts payable
    		                                      
      unrealized losses (gains) on long-term investments
    		                                      
      purchases of short-term investments
    		                                      
      proceeds from public offering, net of cost
    		                                      
      proceeds from sale of ordinary shares, net of cost
    		               0    0 2,069,610,000 0 2,162,407,000                
      unrealized losses on equity investments
    		        10,095,000 2,009,000 169,000   6,555,000 16,974,000                        
      deferred income tax benefits
    		        750,000 -51,000 36,000  -7,170,000 12,836,000 -5,286,000 -2,677,000 -26,097,000 -60,000 -12,251,000 -19,045,000 -7,702,000 -854,000 -206,000 4,102,000 -11,878,000 -473,000 -983,000 -13,150,000 -386,000 -4,323,000 -4,090,000  -1,812,000      
      purchases of investments
    		        -3,999,000 -10,518,000 -1,064,000  -3,231,000 -11,000,000 -504,000  -705,828,000 -592,888,000 -764,163,000 -810,703,000 -2,436,762,000 -1,135,764,000 -1,307,179,000 -318,475,000 -140,034,000 -223,437,000 -487,354,000 -519,176,000 -917,588,000 -566,698,000 -632,224,000        
      unrealized losses (gains) on equity investments
    		           5,583,000                           
      proceeds from research and development cost share liability
    		                   0 0 0 616,834,000                
      payment to acquire joint venture (jv) minority interest
    		                                      
      acquisitions of equipment included in accounts payable
    		            -11,366,000 -4,060,000 62,736,000 11,300,000 13,012,000 -2,021,000 30,906,000 11,836,000 1,964,000 2,550,000 26,412,000  -6,672,000 3,465,000 32,462,000  4,014,000 4,366,000 3,640,000  109,000 -831,000 2,204,000 241,000 -13,000 91,000 
      acquired in-process research and development included in accrued expenses
    		                0                      
      unrealized gains on equity investments
    		               9,534,000                       
      capital contribution from noncontrolling interest
    		                       0 0        0      
      prepayment to acquire joint venture ("jv") minority interest
    		                                      
      unrealized losses/(gains) on equity investments
    		                                      
      repayment of short-term loan
    		                                0      
      unrealized gains on equity method investments
    		                  3,327,000  1,290,000                  
      prepaid expenses and other current assets
    		                  -11,453,000 -12,587,000 1,649,000 -18,515,000 -36,075,000 14,310,000 270,000 -6,265,000 -8,270,000 -12,000,000 -6,633,000 -13,911,000 -13,758,000  -5,931,000      
      other non-current assets
    		                  -6,495,000 15,291,000 -8,608,000 5,338,000 -2,710,000 -5,475,000 -5,014,000 -81,000 -10,212,000 -31,729,000 -4,805,000 -1,612,000 -2,082,000  -496,000      
      tax payable
    		                  7,149,000 14,591,000 -9,266,000 -9,086,000 6,080,000 4,393,000 6,886,000 -4,682,000 969,000 4,252,000 398,000 -8,738,000 733,000  -1,180,000 536,000 1,766,000 126,000 135,000 33,000 
      operating lease liabilities
    		                  1,215,000 -5,414,000 -2,094,000 -3,511,000 10,917,000 7,129,000 1,689,000 -1,167,000 1,550,000            
      other long-term liabilities
    		                  -910,000 1,426,000 -26,778,000 1,207,000 -1,256,000 9,982,000 -1,521,000 -871,000 892,000 4,052,000 13,107,000 -1,130,000 933,000  -379,000 230,000 329,000 82,000   
      deconsolidation of a subsidiary
    		                   0                   
      payment for asset acquisition, net of cash acquired
    		                                      
      proceeds from public offering
    		                                      
      proceeds from public offering and hk ipo
    		                                      
      payment to acquire joint venture ("jv") minority interest
    		                                      
      proceeds from loans
    		                                      
      repayment of loans
    		                                      
      note
    		                                      
      changes in operating assets and liabilities adjusted through accumulated deficit
    		                            0 0 2,291,000        
      operating lease right-of-use assets
    		                    2,258,000 1,525,000 -8,990,000 -7,181,000 -699,000 -2,016,000 -1,588,000            
      proceeds from long-term loans
    		                                      
      repayment of long-term loans
    		                                      
      attributable to beigene, ltd.
    		                                      
      ordinary shares
    		                                      
      shares
    		                                      
      balance at december 31, 2019
    		                                      
      issuance of ordinary shares in connection with collaboration
    		                                      
      use of shares reserved for share option exercises
    		                                      
      exercise of options, espp and release of restricted share units
    		                                      
      share-based compensation
    		                                      
      other comprehensive income
    		                                      
      balance at march 31, 2020
    		                                      
      exercise of options, espp issuances and release of rsus
    		                                      
      use of shares reserved for share option exercises and rsu releases
    		                                      
      other comprehensive loss
    		                                      
      balance at june 30, 2020
    		                                      
      proceeds from issuance of ordinary shares, net of cost
    		                                      
      exercise of options, espp and release of rsus
    		                                      
      issuance of shares reserved for share option exercises
    		                                      
      balance at september 30, 2020
    		                                      
      balance at december 31, 2018
    		                                      
      balance at march 31, 2019
    		                                      
      contributions from shareholders
    		                                      
      gain on deconsolidation of entity
    		                                      
      non-cash interest expense
    		                     2,534,000 2,572,000 2,570,000 1,717,000 1,901,000 1,858,000 1,856,000 1,849,000 2,103,000 2,012,000  2,564,000      
      deconsolidation of entity
    		                                      
      proceeds from long-term bank loan
    		                                      
      proceeds from short-term bank loan
    		                     14,899,000 11,298,000                
      issuance of shares reserved for share option exercises and rsu releases
    		                                      
      balance at june 30, 2019
    		                                      
      benefit from doubtful accounts
    		                      2,022,000                
      unrealized gain on equity securities
    		                      -6,964,000                
      payment for the acquisition of land use right
    		                                      
      cash acquired in business combination, net of cash paid
    		                                      
      proceeds from sale or maturity of available-for-sale securities
    		                             611,443,000 257,568,000  84,028,000 96,287,000 65,613,000    
      proceeds from public offering, net of underwriter discount
    		                             0 758,001,000        
      payment of public offering cost
    		                             0 -414,000        
      proceeds from public offering and hk ipo, net of underwriter discount
    		                                      
      payment of public offering and hk ipo costs
    		                                      
      proceeds from long-term bank loans
    		                       0               
      repayment of long-term bank loans
    		                                      
      proceeds from short-term loan
    		                                0 0 2,470,000    
      proceeds from shareholder loan
    		                                0      
      realized gain on available-for-sale securities
    		                                      
      non-cash amortization of bond discount
    		                        -51,000 -1,244,000 -2,408,000 -3,593,000           
      unbilled receivable
    		                        0 6,114,000 2,498,000 -3,734,000 7,824,000 11,160,000 -7,555,000        
      prepayment of assets acquisition
    		                                      
      proceeds from follow-on public offering, net of underwriter discount
    		                                      
      payment of follow-on public offering cost
    		                                      
      proceeds from hk ipo and global follow-on public offering
    		                                      
      payment of hk ipo and global follow-on public offering costs
    		                                      
      repayment of long-term bank loan
    		                                      
      restricted cash, current
    		                        -296,000 -333,000 14,900,000            
      restricted cash, non-current
    		                        21,240,000 170,000 8,991,000            
      disposal gain on available-for-sale securities
    		                         -996,000 -810,000            
      changes in fair value of financial instruments
    		                                   0 0 1,514,000 
      loss on disposal of property and equipment
    		                           125,000       7,000    
      disposal (gain) loss on available-for-sale securities
    		                                      
      proceeds from disposal of property and equipment
    		                                      
      proceeds from exercise of warrants and rental deferral option
    		                                      
      proceeds from option exercises
    		                           8,803,000 10,277,000 4,268,000 6,314,000        
      discount provided on sale of ordinary shares for business combination
    		                                      
      other non-cash income
    		                             -1,854,000 -482,000        
      net cash from (provided by) investing activities
    		                                      
      restricted cash
    		                             14,131,000 17,460,000        
      non-cash activities:
    		                                      
      cash, cash equivalents, and restricted cash at beginning of year
    		                              239,602,000        
      cash, cash equivalents, and restricted cash at end of year
    		                              508,094,000        
      net effect of foreign exchange rate changes
    		                                      
      net increase in cash and cash equivalents
    		                               31,092,000 -52,496,000 163,256,000 10,236,000 27,448,000 -150,422,000 190,637,000 
      operating activities
    		                                      
      net income /
    		                                      
      adjustments to reconcile net income/(loss) to net cash from operating activities:
    		                                      
      other non-cash expenses
    		                                      
      advances from customers
    		                                      
      investing activities
    		                                      
      purchase of available-for-sale securities
    		                                -436,419,000      
      investment in time deposits
    		                                      
      financing activities
    		                                      
      proceeds from exercise of warrants and options
    		                                  63,000    
      cash and cash equivalents at beginning of period
    		                                0 0 87,514,000 0 0 17,869,000 
      cash and cash equivalents at end of period
    		                                -52,496,000 163,256,000 97,750,000 27,448,000 -150,422,000 208,506,000 
      conversion of senior promissory note
    		                                   0 0 14,693,000 
      conversion of deferred rental
    		                                   0 0 980,000 
      conversion of convertible preferred shares
    		                                   0 0 176,084,000 
      exercise of warrants and options
    		                                      
      initial public offering costs accrued in accrued expenses and other payables
    		                                   0   
      depreciation expense
    		                                 540,000 864,000    
      payment for the acquisition of land use rights
    		                                      
      net cash from / (used in) investing activities
    		                                      
      proceeds from issuance of ordinary shares, net of underwriter discount
    		                                      
      payment of initial public offering cost
    		                                      
      proceeds from employee option exercises
    		                                      
      (gain)/loss on sale of available-for-sale securities
    		                                      
      interest expense
    		                                   25,000 0 93,000 
      payment for land auction deposit
    		                                      
      depreciation expenses
    		                                   505,000 492,000 439,000 
      disposal loss on available-for-sale securities
    		                                   137,000 228,000 712,000 
      proceeds from disposal of available-for-sale securities
    		                                   67,761,000 46,900,000 43,646,000 
      proceeds from issuance of ordinary shares, net of initial public offering costs
    		                                   0 0 167,931,000 
      proceeds from issuance of preferred shares
    		                                      
      payment of convertible preferred shares issuance cost
    		                                      
      conversion of warrant and option liabilities
    		                                   0 0 3,687,000 
      proceeds from exercise of warrants
    		                                    0 2,118,000 
      deferred rental
    		                                      
      initial public offering costs accrued for in accrued expenses and other payables
    		                                     166,000 
      gain on debt extinguishment
    		                                      
      acquisition of non-controlling interest
    		                                      
      proceeds from issuance of convertible promissory notes
    		                                      
      proceeds from issuance of secured guaranteed convertible promissory note
    		                                      
      proceeds from issuance of convertible preferred shares
    		                                      
      proceeds from exercise of share options
    		                                      
      proceeds due to related parties
    		                                      
      repayment to related party
    		                                      
      repayment of subordinated convertible promissory note, convertible promissory notes and secured guaranteed convertible promissory note
    		                                      
      repayment of due to related parties
    		                                      
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.